ArticleCancer research2013

Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients.

Edwin P Hui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.